Product Code: ETC10760894 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Australia Pediatric Diabetes Therapeutic Market Overview |
3.1 Australia Country Macro Economic Indicators |
3.2 Australia Pediatric Diabetes Therapeutic Market Revenues & Volume, 2021 & 2031F |
3.3 Australia Pediatric Diabetes Therapeutic Market - Industry Life Cycle |
3.4 Australia Pediatric Diabetes Therapeutic Market - Porter's Five Forces |
3.5 Australia Pediatric Diabetes Therapeutic Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.6 Australia Pediatric Diabetes Therapeutic Market Revenues & Volume Share, By Administration Route, 2021 & 2031F |
3.7 Australia Pediatric Diabetes Therapeutic Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.8 Australia Pediatric Diabetes Therapeutic Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.9 Australia Pediatric Diabetes Therapeutic Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Australia Pediatric Diabetes Therapeutic Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of pediatric diabetes in Australia |
4.2.2 Technological advancements in diabetes management for children |
4.2.3 Growing awareness about the importance of early diagnosis and treatment of pediatric diabetes |
4.3 Market Restraints |
4.3.1 High cost of pediatric diabetes treatments and medications |
4.3.2 Limited availability of specialized pediatric diabetes healthcare professionals |
4.3.3 Stringent regulatory requirements for pediatric diabetes therapies |
5 Australia Pediatric Diabetes Therapeutic Market Trends |
6 Australia Pediatric Diabetes Therapeutic Market, By Types |
6.1 Australia Pediatric Diabetes Therapeutic Market, By Drug Type |
6.1.1 Overview and Analysis |
6.1.2 Australia Pediatric Diabetes Therapeutic Market Revenues & Volume, By Drug Type, 2021 - 2031F |
6.1.3 Australia Pediatric Diabetes Therapeutic Market Revenues & Volume, By Insulin Therapy, 2021 - 2031F |
6.1.4 Australia Pediatric Diabetes Therapeutic Market Revenues & Volume, By GLP-1 Receptor Agonists, 2021 - 2031F |
6.1.5 Australia Pediatric Diabetes Therapeutic Market Revenues & Volume, By SGLT2 Inhibitors, 2021 - 2031F |
6.1.6 Australia Pediatric Diabetes Therapeutic Market Revenues & Volume, By DPP-4 Inhibitors, 2021 - 2031F |
6.1.7 Australia Pediatric Diabetes Therapeutic Market Revenues & Volume, By Combination Therapies, 2021 - 2031F |
6.2 Australia Pediatric Diabetes Therapeutic Market, By Administration Route |
6.2.1 Overview and Analysis |
6.2.2 Australia Pediatric Diabetes Therapeutic Market Revenues & Volume, By Oral, 2021 - 2031F |
6.2.3 Australia Pediatric Diabetes Therapeutic Market Revenues & Volume, By Injectable, 2021 - 2031F |
6.2.4 Australia Pediatric Diabetes Therapeutic Market Revenues & Volume, By Inhalable, 2021 - 2031F |
6.2.5 Australia Pediatric Diabetes Therapeutic Market Revenues & Volume, By Transdermal, 2021 - 2031F |
6.2.6 Australia Pediatric Diabetes Therapeutic Market Revenues & Volume, By Intravenous, 2021 - 2031F |
6.3 Australia Pediatric Diabetes Therapeutic Market, By Technology |
6.3.1 Overview and Analysis |
6.3.2 Australia Pediatric Diabetes Therapeutic Market Revenues & Volume, By Smart Insulin Pens, 2021 - 2031F |
6.3.3 Australia Pediatric Diabetes Therapeutic Market Revenues & Volume, By Continuous Glucose Monitoring, 2021 - 2031F |
6.3.4 Australia Pediatric Diabetes Therapeutic Market Revenues & Volume, By Artificial Pancreas, 2021 - 2031F |
6.3.5 Australia Pediatric Diabetes Therapeutic Market Revenues & Volume, By Insulin Pumps, 2021 - 2031F |
6.3.6 Australia Pediatric Diabetes Therapeutic Market Revenues & Volume, By AI-Based Diabetes Management, 2021 - 2031F |
6.4 Australia Pediatric Diabetes Therapeutic Market, By Application |
6.4.1 Overview and Analysis |
6.4.2 Australia Pediatric Diabetes Therapeutic Market Revenues & Volume, By Type 1 Diabetes, 2021 - 2031F |
6.4.3 Australia Pediatric Diabetes Therapeutic Market Revenues & Volume, By Type 2 Diabetes, 2021 - 2031F |
6.4.4 Australia Pediatric Diabetes Therapeutic Market Revenues & Volume, By Pre-Diabetes, 2021 - 2031F |
6.4.5 Australia Pediatric Diabetes Therapeutic Market Revenues & Volume, By Hyperglycemia Management, 2021 - 2031F |
6.4.6 Australia Pediatric Diabetes Therapeutic Market Revenues & Volume, By Hypoglycemia Prevention, 2021 - 2031F |
6.5 Australia Pediatric Diabetes Therapeutic Market, By End User |
6.5.1 Overview and Analysis |
6.5.2 Australia Pediatric Diabetes Therapeutic Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.5.3 Australia Pediatric Diabetes Therapeutic Market Revenues & Volume, By Pediatric Clinics, 2021 - 2031F |
6.5.4 Australia Pediatric Diabetes Therapeutic Market Revenues & Volume, By Research Institutes, 2021 - 2031F |
6.5.5 Australia Pediatric Diabetes Therapeutic Market Revenues & Volume, By Home Healthcare, 2021 - 2031F |
6.5.6 Australia Pediatric Diabetes Therapeutic Market Revenues & Volume, By Specialty Centers, 2021 - 2031F |
7 Australia Pediatric Diabetes Therapeutic Market Import-Export Trade Statistics |
7.1 Australia Pediatric Diabetes Therapeutic Market Export to Major Countries |
7.2 Australia Pediatric Diabetes Therapeutic Market Imports from Major Countries |
8 Australia Pediatric Diabetes Therapeutic Market Key Performance Indicators |
8.1 Number of pediatric diabetes cases diagnosed annually |
8.2 Adoption rate of new diabetes management technologies among pediatric patients |
8.3 Percentage of pediatric diabetes patients achieving target HbA1c levels |
8.4 Average age of pediatric diabetes diagnosis |
8.5 Patient satisfaction scores with pediatric diabetes treatment and care services |
9 Australia Pediatric Diabetes Therapeutic Market - Opportunity Assessment |
9.1 Australia Pediatric Diabetes Therapeutic Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.2 Australia Pediatric Diabetes Therapeutic Market Opportunity Assessment, By Administration Route, 2021 & 2031F |
9.3 Australia Pediatric Diabetes Therapeutic Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.4 Australia Pediatric Diabetes Therapeutic Market Opportunity Assessment, By Application, 2021 & 2031F |
9.5 Australia Pediatric Diabetes Therapeutic Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Australia Pediatric Diabetes Therapeutic Market - Competitive Landscape |
10.1 Australia Pediatric Diabetes Therapeutic Market Revenue Share, By Companies, 2024 |
10.2 Australia Pediatric Diabetes Therapeutic Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |